The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-κB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats
Titel:
The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-κB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats
Auteur:
Ochaion, A. Bar-Yehuda, S. Cohen, S. Amital, H. Jacobson, K.A. Joshi, B.V. Gao, Z.G. Barer, F. Patoka, R. Del Valle, L. Perez-Liz, G. Fishman, P.